meglumine antimoniate has been researched along with Co-infection in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Enokihara, MMSS; Gregorio, AW; Guerra, JM; Nonogaki, S; Tomimori, J; Vasconcellos, MRA | 1 |
Barbosa, JF; Caligiorne, RB; de Figueiredo, SM; Lyon, S | 1 |
Abbasi, I; Aguirre, C; Calvopina, M; Castillo, A; Cevallos, W; Warburg, A | 1 |
3 other study(ies) available for meglumine antimoniate and Co-infection
Article | Year |
---|---|
Cutaneous schistosomiasis and leishmaniasis coinfection: a case report.
Topics: Adult; Antiprotozoal Agents; Biopsy; Coinfection; Diagnosis, Differential; Female; Humans; Leishmaniasis, Cutaneous; Meglumine Antimoniate; Schistosomiasis; Skin Diseases, Parasitic | 2019 |
An 8-Year Retrospective Study of Human Visceral Leishmaniasis.
Topics: Adolescent; Adult; Amphotericin B; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Coinfection; Female; HIV Infections; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Retrospective Studies; Sex Distribution; Young Adult | 2016 |
Coinfection of
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Coinfection; Cytochromes b; Fatal Outcome; HIV; HIV Infections; Humans; Leishmania guyanensis; Leishmaniasis, Diffuse Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Protozoan Proteins; Sequence Analysis, DNA; Shock, Septic; Skin; Treatment Failure | 2017 |